- Home
- REAX vs VIR Comparison
REAX vs VIR Comparison
Compare REAX & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REAX
- VIR
- Stock Information
- Founded
- REAX 2018
- VIR 2016
- Country
- REAX United States
- VIR United States
- Employees
- REAX N/A
- VIR N/A
- Industry
- REAX
- VIR Biotechnology: Pharmaceutical Preparations
- Sector
- REAX
- VIR Health Care
- Exchange
- REAX Nasdaq
- VIR Nasdaq
- Market Cap
- REAX 1.1B
- VIR 1.0B
- IPO Year
- REAX N/A
- VIR 2019
- Fundamental
- Price
- REAX $4.89
- VIR $7.37
- Analyst Decision
- REAX Strong Buy
- VIR Buy
- Analyst Count
- REAX 2
- VIR 5
- Target Price
- REAX $5.25
- VIR $36.40
- AVG Volume (30 Days)
- REAX 773.3K
- VIR 1.5M
- Earning Date
- REAX 11-07-2024
- VIR 10-31-2024
- Dividend Yield
- REAX N/A
- VIR N/A
- EPS Growth
- REAX N/A
- VIR N/A
- EPS
- REAX N/A
- VIR N/A
- Revenue
- REAX $1,095,350,000.00
- VIR $78,618,000.00
- Revenue This Year
- REAX $79.06
- VIR N/A
- Revenue Next Year
- REAX $30.06
- VIR N/A
- P/E Ratio
- REAX N/A
- VIR N/A
- Revenue Growth
- REAX 81.37
- VIR N/A
- 52 Week Low
- REAX $1.46
- VIR $6.56
- 52 Week High
- REAX $6.75
- VIR $13.09
- Technical
- Relative Strength Index (RSI)
- REAX 41.36
- VIR 42.68
- Support Level
- REAX $4.83
- VIR $7.25
- Resistance Level
- REAX $5.35
- VIR $7.83
- Average True Range (ATR)
- REAX 0.23
- VIR 0.51
- MACD
- REAX -0.03
- VIR -0.09
- Stochastic Oscillator
- REAX 13.59
- VIR 2.18
About REAX The Real Brokerage Inc.
The Real Brokerage Inc is a technology-powered real estate brokerage firm. It has developed, integrated, and adopted various mobile and desktop-focused technologies to create a comprehensive offering to its agents and to assist Real with its brokerage operations. The group delivers a cloud-based platform to improve efficiencies and empower real estate agents to provide a seamless end-to-end experience for homebuyers and sellers. The company generates its maximum revenue from the United States.
About VIR Vir Biotechnology Inc.
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.